Cargando…

Neonatal Fc receptor promoter gene polymorphism does not predict pharmacokinetics of IVIg or the clinical course of GBS

Treatment of Guillain‐Barré syndrome with a standard course of high‐dose intravenous immunoglobulin (IVIg) results in a variable clinical recovery which is associated with changes in serum IgG levels after treatment. The neonatal Fc‐receptor protects IgG from degradation, and a genetic polymorphism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fokkink, Willem‐Jan R., Haarman, Annechien E. G., Tio‐Gillen, Anne P., van Rijs, Wouter, Huizinga, Ruth, van Doorn, Pieter A., Jacobs, Bart C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931719/ https://www.ncbi.nlm.nih.gov/pubmed/27386503 http://dx.doi.org/10.1002/acn3.307

Ejemplares similares

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome
por: Thomma, Robin C.M., et al.
Publicado: (2023)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Comparison of Fc N-Glycosylation of Pharmaceutical Products of Intravenous Immunoglobulin G
por: Fokkink, Willem Jan R., et al.
Publicado: (2015)

Occurrence of hemolytic anemia in patients with GBS treated with high-dose IVIg
por: Nguyen, Thy P., et al.
Publicado: (2014)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Developing the IVIG biomimetic, Hexa-Fc, for drug and vaccine applications
por: Czajkowsky, Daniel M., et al.
Publicado: (2015)

Randomized trial of three IVIg doses for treating chronic inflammatory demyelinating polyneuropathy
por: Cornblath, David R, et al.
Publicado: (2022)

Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
por: Nagelkerke, Sietse Q., et al.
Publicado: (2015)

Guillain-Barré Syndrome-Related Campylobacter jejuni in Bangladesh: Ganglioside Mimicry and Cross-Reactive Antibodies
por: Islam, Zhahirul, et al.
Publicado: (2012)

GBS-SBG - GBS Serotyping by Genome Sequencing
por: Tiruvayipati, Suma, et al.
Publicado: (2021)

Incidence of maternal GBS colonization and neonatal GBS disease among Very Low Birth Weight Polish neonates
por: Brzychczy-Wloch, Monika, et al.
Publicado: (2013)

Role of HIV exposure and infection in relation to neonatal GBS disease and rectovaginal GBS carriage: a systematic review and meta-analysis
por: Cools, Piet, et al.
Publicado: (2017)

Plasma exchange (PE) versus intravenous immunoglobulin (IVIG) for the treatment of Guillain-Barré syndrome (GBS) in patients with severe symptoms: A systematic review and meta-analysis
por: Zaki, Hany A., et al.
Publicado: (2023)

NanoGBS: A Miniaturized Procedure for GBS Library Preparation
por: Torkamaneh, Davoud, et al.
Publicado: (2020)

Validation and adjustment of modified Erasmus GBS outcome score in Bangladesh
por: Papri, Nowshin, et al.
Publicado: (2022)

Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc
por: Traets, Marissa J.M., et al.
Publicado: (2020)

The importance of FcRn in neuro-immunotherapies: From IgG catabolism, FCGRT gene polymorphisms, IVIg dosing and efficiency to specific FcRn inhibitors
por: Dalakas, Marinos C., et al.
Publicado: (2021)

epiGBS2: Improvements and evaluation of highly multiplexed, epiGBS‐based reduced representation bisulfite sequencing
por: Gawehns, Fleur, et al.
Publicado: (2022)

Individualizing Therapy in CIDP: A Mini-Review Comparing the Pharmacokinetics of Ig With SCIg and IVIg
por: Beydoun, Said R., et al.
Publicado: (2021)

Treatment of scleromyxedema with IVIg
por: Moser, David W, et al.
Publicado: (2012)

Methylprednisolone Pulse Therapy or Additional IVIG for Patients with IVIG-Resistant Kawasaki Disease
por: Wang, Zhouping, et al.
Publicado: (2020)

A comparison of GenomEra® GBS PCR and GeneXpert ® GBS PCR assays with culture of GBS performed with and without broth pre-enrichment
por: Nielsen, S. Y., et al.
Publicado: (2020)

Evaluation of Xpert GBS assay and Xpert GBS LB assay for detection of Streptococcus agalactiae
por: Han, Meng-Yi, et al.
Publicado: (2021)

A Comparative Study of IVIG versus IVIG with IV Methylprednisolone in Guillain–Barre Syndrome
por: Bhattiprolu, Rahi Kiran, et al.
Publicado: (2020)

Mechanism of increased efficacy of recombinant Fc‐μTP‐L309C compared to IVIg to ameliorate mouse immune thrombocytopenia
por: Lewis, Bonnie J.B., et al.
Publicado: (2021)

Performance of BD MAX Group B Streptococcus (GBS) Assay without Enrichment for the Detection of GBS
por: Um, Sewhan, et al.
Publicado: (2022)

Cooling down VITT with IVIG
por: Lentz, Steven R.
Publicado: (2021)

Intravenous Immunoglobulin Gamma (IVIG) versus IVIG Plus Infliximab in Young Children with Kawasaki Disease
por: Han, Chun-Ling, et al.
Publicado: (2018)

Sialylation of Campylobacter jejuni Lipo-Oligosaccharides: Impact on Phagocytosis and Cytokine Production in Mice
por: Huizinga, Ruth, et al.
Publicado: (2012)

Safety, Efficacy and Pharmacokinetics of a New 10% Liquid Intravenous Immunoglobulin (IVIG) in Patients with Primary Immunodeficiency
por: Wasserman, Richard L., et al.
Publicado: (2012)

Study on the Treatment of ITP Mice with IVIG Sourced from Distinct Sex-Special Plasma (DSP-IVIG)
por: Zhang, Wei, et al.
Publicado: (2023)

Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics
por: Piche-Nicholas, Nicole M., et al.
Publicado: (2017)

The GBS PI-2a Pilus Is Required for Virulence in Mice Neonates
por: Papasergi, Salvatore, et al.
Publicado: (2011)

GBS and COVID-19: Untangling the Knots
por: Alcantara, Monica, et al.
Publicado: (2022)

IVIG-Associated Maternal Pancytopenia during Treatment for Neonatal Alloimmune Thrombocytopenia
por: Herrmann, Alyssa, et al.
Publicado: (2017)

Two case reports and a literature review of typical GBS and rare GBS variants associated with COVID-19
por: Orak, Sibğatullah Ali, et al.
Publicado: (2023)

IgG Glyco-Engineering to Improve IVIg Potency
por: Bruggeman, Christine W., et al.
Publicado: (2018)

A Prospective, Multicenter, Randomized Phase II Study to Evaluate the Efficacy and Safety of Eculizumab in Patients with Guillain-Barré Syndrome (GBS): Protocol of Japanese Eculizumab Trial for GBS (JET-GBS)
por: Yamaguchi, Nobuko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_12oi1sq5l0kes7k99d6dnqbnsl